Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia

Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia

Anemia remains an essential concern affecting the quality of life and the survival of cancer patients. Although there are different approaches to treating anemia in cancer patients, the number of studies reporting the efficacy of iron replacement in cancer patients is limited. In this study, the eff...

Full description

Bibliographic Details
Main Authors: Burak Yasin Aktaş, Emine Büşra Ata, Engin Çeşmeci, İbrahim Yahya Çakır, Muharrem Coşkunpınar, Yağmur Tahillioğlu, Gürkan Güner, Deniz Can Güven, Zafer Arık, Neyran Kertmen, Ömer Dizdar, Şuayib Yalçın, Sercan Aksoy
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Current Oncology
Subjects:
iron deficiency
ferric carboxymaltose
cancer-related anemia
Online Access:https://www.mdpi.com/1718-7729/30/11/703

Internet

https://www.mdpi.com/1718-7729/30/11/703

Similar Items